Answers are grounded in this paper and cite their sources.
In Fe-deficient predialysis patients, intravenous Fe therapy is associated with increases in LIC unrelated to changes in conventional Fe markers. In hemodialysis patients, TSAT and ferritin are poor indicators of body Fe load, and some patients have LICs similar to those found in hemochromatosis.
No takes yet. Share an insight, caveat, or question.
Ferrari et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: